• Godoy Myrna C B MCB Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: mgodoy@mdanderson.org., Erika G L C Odisio, Jeremy J Erasmus, Rodrigo C Chate, Ricardo S Dos Santos, and Mylene T Truong.
• Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: mgodoy@mdanderson.org.
• Semin. Ultrasound CT MR. 2018 Jun 1; 39 (3): 260-272.

AbstractLung cancer is the leading cause of cancer death in both men and women in the United States. The National Lung Screening Trial (NLST) demonstrated that low-dose computed tomography (CT) screening reduces lung cancer mortality by 20% compared to screening with chest radiography. Currently, many institutions in the US are implementing lung cancer screening programs. The use of lung-RADS as a quality assurance tool allows standardization of lung cancer screening CT lexicon, reporting and management recommendations, and reduces confusion in lung cancer screening CT interpretations. Lung-RADS will also facilitate outcome monitoring and future auditing of lung cancer screening programs, assist research, and consequently refine and improve lung cancer screening practices. Familiarity with lung-RADS version 1.0 is essential not only for radiologists interpreting low-dose computed tomography screening studies, but all medical personnel involved in multidisciplinary lung cancer screening programs. This article reviews the Lung-RADS categories and management recommendations using a case-based approach.Copyright © 2018 Elsevier Inc. All rights reserved.

9 keywords...

hide…